HomeNVV1 • FRA
add
Novavax Inc
Nakaraang pagsara
€8.33
Sakop ng araw
€7.84 - €8.12
Sakop ng taon
€3.33 - €23.93
Market cap
1.33B USD
Average na Volume
3.88K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Reuters
1 buwan ang nakalipas
US FDA pauses Novavax's trial of combo COVID-flu shot on safety concerns
1.31%
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 84.51M | -54.80% |
Gastos sa pagpapatakbo | 66.95M | -37.70% |
Net na kita | -121.30M | 7.25% |
Net profit margin | -143.53 | -105.22% |
Kita sa bawat share | -0.76 | 39.68% |
EBITDA | -117.12M | -2.46% |
Aktuwal na % ng binabayarang buwis | 0.84% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 909.53M | 39.69% |
Kabuuang asset | 1.71B | 3.34% |
Kabuuang sagutin | 2.24B | -4.14% |
Kabuuang equity | -526.44M | — |
Natitirang share | 160.18M | — |
Presyo para makapag-book | -2.53 | — |
Return on assets | -18.38% | — |
Return on capital | 150.12% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -121.30M | 7.25% |
Cash mula sa mga operasyon | -144.81M | -265.18% |
Cash mula sa pag-invest | 31.91M | 273.52% |
Cash mula sa financing | -97.00K | -100.05% |
Net change in cash | -106.97M | -172.07% |
Malayang cash flow | -78.48M | -210.04% |
Tungkol
Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases. Prior to 2020, company scientists developed experimental vaccines for influenza and respiratory syncytial virus, as well as Ebola and other emerging infectious diseases. During 2020, the company redirected its efforts to focus on development and approval of its NVX-CoV2373 vaccine for COVID-19.
The COVID-19 vaccine Nuvaxovid was approved in the European Union at the end of 2021, and in Canada in February 2022, as the fifth vaccine against COVID-19, following Pfizer/BioNTech, Moderna, Janssen and AstraZeneca. Wikipedia
Itinatag
1987
Headquarters
Website
Mga Empleyado
1,543
